Ventus Therapeutics
Dan McKay is the Founder of ReSOLVE and Director of Computation Chemistry at Ventus Therapeutics. Dan has over 24 years of industrial drug discovery experience previously with Novartis and the Merck Frosst Centre for Therapeutic Research. He is co-author of over 45 publications and over 24 patents.
Dan received his BSc in Chemistry and MSc in Theoretical Chemistry from Carleton University in Professor James Wright’s group.
This person is not in any offices
Ventus Therapeutics
1 followers
Ventus Therapeutics is advancing the next frontier for structure-based drug design to navigate elusive targets, in Montreal and Waltham, MA.